Showing results (181-190 of 201) with videos related to
Sort By:
Pageof 21
The New England Journal of Medicine|December 9, 2024
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta, Rachel E Rau, John A Kairalla, et al.Transplantation and Cellular Therapy|March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeMelissa R Hines, Tristan E Knight, Kevin O McNerney, et al.Hemasphere|November 27, 2025
Leveraging genomic diagnostics for prognostics and therapeutics in pediatric acute leukemiaHaley Newman, Derek Wong, Jinhua Wu, et al.The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.The Journal of Clinical Investigation|June 9, 2026
Aberrant STAT signaling and T cell dysregulation define a targetable pediatric sepsis endotypeRobert B Lindell, Samir U Sayed, Jose S Campos Duran, et al.Blood Advances|February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemiaJason Xu, Michael McCoy, Zachary Martinez, et al.Journal of the National Cancer Institute|August 20, 2025
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohortDaniel J Zheng, Gary Hettinger, Catherine Aftandilian, et al.Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19Laura Vella, Josephine R Giles, Amy E Baxter, et al.The Journal of Clinical Investigation|July 31, 2020
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2Caroline Diorio, Sarah E Henrickson, Laura A Vella, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and LymphomaDavid T Teachey, Meenakshi Devidas, Brent L Wood, et al.Pageof 21